Skip to main content
icon for Flu Hospitalization Rate Week 17, 2026?

Flu Hospitalization Rate Week 17, 2026?

icon for Flu Hospitalization Rate Week 17, 2026?

Flu Hospitalization Rate Week 17, 2026?

May 1

May 8

May 1

May 8

85–90 89%

<80 8%

90–95 5%

80–85 3.0%

Polymarket
NEW

85–90 89%

<80 8%

90–95 5%

80–85 3.0%

Polymarket
NEW

<80

$48 Vol.

8%

80–85

$48 Vol.

3%

85–90

$48 Vol.

89%

90–95

$48 Vol.

5%

95–100

$48 Vol.

3%

100+

$124 Vol.

1%

This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.Traders' strong consensus on the 85–90 range (88.5% implied probability) for Week 17's cumulative influenza-associated hospitalization rate stems from the CDC's latest FluView report for Week 15 (ending April 18, 2026), which recorded 85.2 per 100,000 population via FluSurv-NET surveillance—third highest since 2010–11 but plateauing as seasonal activity declines. The weekly rate fell to 0.5 per 100,000 (from 0.7 in Week 14), signaling waning transmission amid a shift to influenza B viruses after A(H3N2) dominance. With low weekly additions expected (FluSight ensemble forecasts national hospital admissions decreasing), minimal cumulative growth positions higher brackets unlikely; Week 16 data, due imminently, could confirm trends before Week 17 resolution.

This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.

If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.

The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.

Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Volume
$363
End Date
May 8, 2026
Market Opened
Apr 30, 2026, 2:36 PM ET

Resolver

0x69c47De9D...
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.Traders' strong consensus on the 85–90 range (88.5% implied probability) for Week 17's cumulative influenza-associated hospitalization rate stems from the CDC's latest FluView report for Week 15 (ending April 18, 2026), which recorded 85.2 per 100,000 population via FluSurv-NET surveillance—third highest since 2010–11 but plateauing as seasonal activity declines. The weekly rate fell to 0.5 per 100,000 (from 0.7 in Week 14), signaling waning transmission amid a shift to influenza B viruses after A(H3N2) dominance. With low weekly additions expected (FluSight ensemble forecasts national hospital admissions decreasing), minimal cumulative growth positions higher brackets unlikely; Week 16 data, due imminently, could confirm trends before Week 17 resolution.

This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.

If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.

The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.

Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Volume
$363
End Date
May 8, 2026
Market Opened
Apr 30, 2026, 2:36 PM ET

Resolver

0x69c47De9D...
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.

Related

icon for US fertility rate up in Q1 2026?

US fertility rate up in Q1 2026?

19%
icon for Will US unemployment reach at least 5.0% in 2026?

Will US unemployment reach at least 5.0% in 2026?

46%
icon for Will inflation reach more than 3.5% in 2026?

Will inflation reach more than 3.5% in 2026?

95%

Beware of external links.

Frequently Asked Questions

"Flu Hospitalization Rate Week 17, 2026?" is a prediction market on Polymarket with 6 possible outcomes where traders buy and sell shares based on what they believe will happen. The current leading outcome is "85–90" at 89%, followed by "90–95" at 5%. Prices reflect real-time crowd-sourced probabilities. For example, a share priced at 89¢ implies that the market collectively assigns a 89% chance to that outcome. These odds shift continuously as traders react to new developments and information. Shares in the correct outcome are redeemable for $1 each upon market resolution.

"Flu Hospitalization Rate Week 17, 2026?" is a newly created market on Polymarket, launched on Apr 30, 2026. As an early market, this is your opportunity to be among the first traders to set the odds and establish the market's initial price signals. You can also bookmark this page to track volume and trading activity as the market gains traction over time.

To trade on "Flu Hospitalization Rate Week 17, 2026?," browse the 6 available outcomes listed on this page. Each outcome displays a current price representing the market's implied probability. To take a position, select the outcome you believe is most likely, choose "Yes" to trade in favor of it or "No" to trade against it, enter your amount, and click "Trade." If your chosen outcome is correct when the market resolves, your "Yes" shares pay out $1 each. If it's incorrect, they pay out $0. You can also sell your shares at any time before resolution if you want to lock in a profit or cut a loss.

The current frontrunner for "Flu Hospitalization Rate Week 17, 2026?" is "85–90" at 89%, meaning the market assigns a 89% chance to that outcome. The next closest outcome is "90–95" at 5%. These odds update in real-time as traders buy and sell shares, so they reflect the latest collective view of what's most likely to happen. Check back frequently or bookmark this page to follow how the odds shift as new information emerges.

The resolution rules for "Flu Hospitalization Rate Week 17, 2026?" define exactly what needs to happen for each outcome to be declared a winner — including the official data sources used to determine the result. You can review the complete resolution criteria in the "Rules" section on this page above the comments. We recommend reading the rules carefully before trading, as they specify the precise conditions, edge cases, and sources that govern how this market is settled.